A Trial to Evaluate Faropenem Medoxomil in the Treatment of Acute Otitis Media

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The study will be conducted in infants and children with acute otitis media, 6 months to less than 7 years old, in Costa Rica and Israel. The primary objective of this trial will be to describe bacteriologic efficacy in those with initial culture positive specimens with different dosages of faropenem

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Replidyne
• Treatments: beta-Lactams

Criteria

Inclusion Criteria:

• Acute Otis Media

Exclusion Criteria:

• Any antibiotic for more than 24 hours (unless a treatment failure) within 7 days prior to enrollment